That definition requires use of a panel of mono- and dinucleotide microsatellite markers that are strongly associated with loss of DNA MMR protein expression, and can identify colorectal cancers from patients that might influence their outcome and response to chemotherapy [6,7,8]. This evidence concerns the gene MRC1 and colorectal cancer.